Marine Drugs (Jul 2015)

Identification of the Scopularide Biosynthetic Gene Cluster in Scopulariopsis brevicaulis

  • Mie Bech Lukassen,
  • Wagma Saei,
  • Teis Esben Sondergaard,
  • Anu Tamminen,
  • Abhishek Kumar,
  • Frank Kempken,
  • Marilyn G. Wiebe,
  • Jens Laurids Sørensen

DOI
https://doi.org/10.3390/md13074331
Journal volume & issue
Vol. 13, no. 7
pp. 4331 – 4343

Abstract

Read online

Scopularide A is a promising potent anticancer lipopeptide isolated from a marine derived Scopulariopsis brevicaulis strain. The compound consists of a reduced carbon chain (3-hydroxy-methyldecanoyl) attached to five amino acids (glycine, l-valine, d-leucine, l-alanine, and l-phenylalanine). Using the newly sequenced S. brevicaulis genome we were able to identify the putative biosynthetic gene cluster using genetic information from the structurally related emericellamide A from Aspergillus nidulans and W493-B from Fusarium pseudograminearum. The scopularide A gene cluster includes a nonribosomal peptide synthetase (NRPS1), a polyketide synthase (PKS2), a CoA ligase, an acyltransferase, and a transcription factor. Homologous recombination was low in S. brevicaulis so the local transcription factor was integrated randomly under a constitutive promoter, which led to a three to four-fold increase in scopularide A production. This indirectly verifies the identity of the proposed biosynthetic gene cluster.

Keywords